HEMATOLOGIC CANCER

This study is testing a new care model called OPTIMISE, designed to improve overall health for cancer patients who also have other chronic conditions like diabetes or high blood pressure. It focuses on better communication and coordination between a patient's cancer doctor and th…

This study is testing a new support program for cancer survivors who struggle to afford or access healthy food. Researchers will compare 100 patients who receive help from a patient navigator to those getting standard care, to see if the program improves food security, diet quali…

This study is testing whether some multiple myeloma patients who are in a very deep, sustained remission can safely stop their long-term maintenance therapy. It will enroll about 70 patients who have been on therapy for at least two years and have no signs of cancer in very sensi…

This study is testing whether hypnosis can help reduce anxiety in people recently diagnosed with certain types of blood cancer (lymphoma). Researchers will measure anxiety levels in 50 patients before and after they receive 2-3 hypnosis sessions over 3 months. The goal is to see …

This study is testing whether simple, non-drug approaches can help reduce brain-related side effects (neurotoxicity) that sometimes occur after a powerful cancer treatment called CAR-T therapy. Researchers will enroll 100 adults with blood cancers and randomly assign them to eith…

This study aims to better predict which blood cancer patients are at high risk for dangerous side effects, like cytokine release syndrome (CRS), after receiving immunotherapy. Researchers will monitor 100 patients continuously with wireless sensors and blood tests to look for ear…

This study aims to collect detailed genetic information and health records from 25,000 adults who have cancer or are at risk of developing it. Researchers will analyze this data to better understand how cancer develops and to identify potential targets for future treatments. The …

This study tests a support program designed to help Black, Latino, and older adult cancer patients overcome barriers to getting genetic testing. Genetic testing is often required to qualify for newer, targeted cancer treatments and clinical trials. The program includes a patient …